ORM Genomics Program
As a division of Oregon Reproductive Medicine (ORM), we have improved fertility treatment outcomes for countless patients. We use the latest genomic technologies to aid patients with infertility in achieving success with fertility treatments, and to help those who wish to reduce their chance of having a child with a specific genetic condition.
Understanding of the genomics of fertility is continuously evolving, and ORM is paving the way. While these advances help improve reproductive outcomes, we also pride ourselves on patient education through this website, patient seminars and written materials, and our talented team of experienced genetic counselors. We empower our patients to make decisions with accurate, up-to-date, and easy to understand information.
We use genomics in many ways to improve healthy outcomes:
All ORM patients undergoing IVF are offered comprehensive chromosome screening (CCS) by their physician to improve the chance of a healthy pregnancy. This website provides answers to commonly asked questions about CCS.
All patients new to ORM are offered genetic carrier screening to help assess their risk for having a child with a genetic disorder. We strive to provide you with information to help make an informed decision about this testing option.
Genetic counseling at ORM will be recommended to you if you are an IVF patient and are considering chromosomal or genetic screening of your embryos. Genetic counseling empowers you to play an active role in decision-making about your treatment, and can be helpful if you have a personal or family history of a genetic disease or are known to be a carrier of a genetic disorder or chromosomal condition.
If you and/or your partner carry a genetic condition or chromosome change that could affect your future family, you may wish to undergo IVF with preimplantation genetic diagnosis (PGD) to reduce the risk of having a child with the condition.
Donor Egg & Surrogacy
If you are undergoing donor egg IVF and/or are using a surrogate, you may benefit from CCS, carrier screening, and genetic counseling as well. Because of the increased complexity of these cycles, genomic technologies may be integrated to improve the chance of a healthy outcome.